Skip to search formSkip to main contentSkip to account menu

indacaterol

Known as: 5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one 
National Institutes of Health

Related topics

Related topics

10 relations
Adrenergic beta2-Agonists [MoA]Glycopyrrolate 0.0156 MG / indacaterol 0.0275 MG Inhalant Powder [Utibron]indacaterol 0.075 MG Inhalant Powderindacaterol 0.075 MG Inhalant Powder [Arcapta]

Broader (2)

IndansQuinolones

Narrower (4)

OnbrezQAB-149arcapta neohalerindacaterol maleate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study
BackgroundChronic obstructive pulmonary disease (COPD) is a progressive disease and a composite endpoint could be an indicator of… 
2017
2017
The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
Background Endpoints that evaluate deterioration rather than improvement of disease may have clinical utility in COPD. In this… 
Highly Cited
2010
Highly Cited
2010
Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol
Abstract Objective: To report performance characteristics and robustness of the Breezhaler device, a new capsule based dry powder… 
2009
2009
24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterol
ABSTRACT Objective: To assess the bronchodilator efficacy, safety and tolerability of indacaterol, a novel, once-daily inhaled β2… 
2008
2008
A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors.
Review
2008
Review
2008
New approaches to managing asthma: a US perspective
Despite remarkable advances in diagnosis and long-term management, asthma remains a serious public health concern. Newly updated… 
2007
2007
Indacaterol provides sustained 24 h bronchodilation on once‐daily dosing in asthma: a 7‐day dose‐ranging study
Background: Indacaterol is a novel, once‐daily β2‐agonist in development for the treatment of asthma and chronic obstructive… 
2007
2007
Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma
ABSTRACT Objective: This study compared the bronchodilator efficacy and safety of indacaterol with placebo, salbutamol and… 
Highly Cited
2005
Highly Cited
2005
Synthesis of 5-substituted-1H-indol-2-yl-1H-quinolin-2-ones: a novel class of KDR kinase inhibitors.
[reaction: see text] A number of approaches for the synthesis of the 1H-indol-2-yl-1H-quinolin-2-one ring system found in the… 
2005
2005
Concerns in the development of an assay for determination of a highly conjugated adsorption-prone compound in human urine.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)